CrossRef The PREVAIL trial of enzalutamide in men with chemotherapy-nave, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients Choung-Soo Kim, Ad Theeuwes, Dong Deuk Kwon, Young Deuk Choi, Byung Ha Chung, Hyun Moo Lee, Kang Hyun Lee, Sang Eun Lee Investigative and Clinical Urology.2016
J Plant Physiol 203:6983
Light peels show results in about 12 weeks
Andreeff M , Wulf G, Weidner DA, Wang RY, Zhao S, Kuenle I, Marini F, Estey E, Kantarjian H, Brenner MK, Goodell MA
Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells